Register of
Medicinal Products

Product class: Authorized package
Medicinal product class: For human use
Package code: 1379820
Name of medicinal product: ALFUZOSIN-TEVA
Active substances:
Alfuzosin
Estonian, English, Latin
ATC code: G04CA01
Dosage form: prolonged-release tablet
Route of administration: oral use
Strengh: 10mg
Amount in package: 10TK
Legal status for supply*: Subject to medicinal prescription
Class of active substance:  
Additional information:  
Indication: Treatment of moderate to severe functional symptoms of benign prostatic hyperplasia (BPH).
Safety features: Yes
Summary of product characteristics (SPC):  (last updated June 21, 2016)
Package information leaflet (PIL): EST  (last updated April 1, 2021)
Labelling:  (last updated May 31, 2018)
Last imported to Estonia: Never imported to Estonia
Marketing authorization holder: Teva Pharma B.V. 
Marketing authorization number: 556507 
Marketing authorization issued on: August 24, 2007 
Marketing authorization expires on: Unlimited 
Marketing authorization procedure type: Mutual recognition 
Reference price:   
Under reference price:   
Reference price of daily dose:   
Entry/Changing date: April 1, 2021
Legal status for supply – medicinal product on medical prescription or not subject to medical prescription

You can download Acrobat Reader fromhere